OTO-104 for Meniere's Disease

NCT01084525 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Meniere's Disease

Interventions

DRUG: OTO-104 (steroid) 3 mg
DRUG: Placebo
DRUG: OTO-104 (steroid) 12 mg

Sponsor

Otonomy, Inc.